Pharmafile Logo

FIT

- PMLiVE

Industry concerned about ‘rushed’ Brexit withdrawal legislation

The Patents Amendment could weaken the UK’s IP framework, warns biopharma

- PMLiVE

Fishawack acquires creative consultancy Blue Latitude Health

The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy...

Avalere Health

We’ve moved!

Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.

Blue Latitude Health

- PMLiVE

Blue Latitude Health joins Fishawack Group of Companies

Blue Latitude Health announces a new partnership with Fishawack Group of Companies, fuelling our global growth.

Blue Latitude Health

- PMLiVE

Beneluxa: the future of European market access?

Andrew McConaghie talks to Beneluxa’s Marcel van Raaij and Biogen’s Erik Smet about their groundbreaking deal on Spinraza and what it means for European market access

- PMLiVE

eConsent: Busting regulatory myths

‘eConsent improves the way consent is obtained, helps keep participants better informed and easily tracks study progress results’

- PMLiVE

Digital applications are transforming the market access landscape

Optimising product value through digital technology

The European Medicines Agency: PRIME’d for access?

Leela Barham examines the impact of the EMA's PRIME fast track system after two years

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

Research Partnership

- PMLiVE

Understanding HCPs to build a meaningful brand

In the regulated world of pharmaceutical marketing,  how can a brand build a meaningful relationship with its customers? This article explores healthcare professionals’ (HCPs) perceptions of pharmaceutical companies, using analysis of...

Segmentation, evolved

My research into the evolution of the life science industry reveals broad, sweeping trends, as I wrote about in previous PME articles such as “Selection Pressures” and “Explosive Evolution”. But...

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links